Mirae Asset Global Investments’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.2K Sell
707
-101
-13% -$2.78K ﹤0.01% 1476
2026
Q1
$16.3K Buy
808
+55
+7% +$1.06K ﹤0.01% 1457
2025
Q4
$15.5K Buy
753
+201
+36% +$5K ﹤0.01% 1563
2025
Q3
$9.57K Buy
552
+1
+0.2% +$20 ﹤0.01% 1579
2025
Q2
$8.24K Buy
551
+60
+12% +$942 ﹤0.01% 1508
2025
Q1
$7.13K Sell
491
-4
-0.8% -$69 ﹤0.01% 1496
2024
Q4
$11.4K Buy
+495
New +$18.4K ﹤0.01% 1496

Other funds holding NGNE

Mirae Asset Global Investments's NGNE Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Neurogene (NGNE) stake by 13% in Q2 2026, selling an estimated $2.78K and leaving 707 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

Mirae Asset Global Investments first reported a position in NGNE in Q4 2024 and has held it in 7 quarters since. 17 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Mirae Asset Global Investments held 707 shares of Neurogene worth $22.2K as of Q2 2026.
  • Mirae Asset Global Investments sold 101 Neurogene shares in Q2 2026, an estimated $2.78K.
  • Neurogene made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1476 holding.
  • Mirae Asset Global Investments first reported a position in Neurogene in Q4 2024 and has held it in 7 quarters since.
  • 17 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.